Form 8-K Opexa Therapeutics, Inc. For: Oct 31

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. AXP
9. ZETA
10. DAL

Go back to Form 8-K Opexa Therapeutics, Inc. For: Oct 31

Opexa Therapeutics (OPXA) Announces 40% Workforce Reduction

November 2, 2016 7:48 AM EDT

Opexa Therapeutics (Nasdaq: OPXA) nnounced that it was implementing an approximately 40% reduction to the Companys current workforce in order to reduce operating expenses and conserve cash resources. The move comes as the Company recently announced that the Phase 2b Abili-T clinical trial designed to evaluate the efficacy and safety of Tcelna® (imilecleucel-T) in patients with secondary progressive multiple sclerosis (SPMS) did not meet its primary endpoint... More